ニュース

The city of Rockford dedicated a memorial plaque to one of their own, who died of a form of muscular dystrophy in November.
CureDuchenne, a global nonprofit based in Newport Beach that is dedicated to funding and finding a cure for Duchenne muscular ...
Mikey, who lived with Duchenne muscular dystrophy, passed away earlier this month at the age of 21. His funeral, held at ...
Sarcomatrix Therapeutics, a biopharmaceutical company developing small‑molecule treatments for Duchenne muscular dystrophy (DMD), today announced it has received a $300,000 investment from Nevada’s ...
This weekend, the Rockford community will come together once again for the 27th Annual Mitchell's Run Thru Rockford (MRTR), a USATF-certified 5K run/walk and Kids K benefiting Parent Project Muscular ...
Echocardiography may be at the vanguard for early and rapid detection of heart issues indicative of Duchenne muscular ...
US FDA grants orphan drug designation to Keros Therapeutics’ KER-065 to treat Duchenne muscular dystrophy: Lexington, Massachusetts Friday, August 22, 2025, 15:00 Hrs [IST] Kero ...
The FDA’s shift on Elevidys sends a message: boldness, scientific rigor and urgency are essential in confronting rare ...
Duchenne muscular dystrophy is the most frequent inherited muscle disease and no cure is available. The condition is currently treated with corticosteroids, which can cause substantial side effects.
Discover the challenges and opportunities for Keros Therapeutics, Inc., including FDA designations, partnerships, and ...
Certain Sarepta Therapeutics Inc. insiders were accused in a stockholder lawsuit of reaping a combined $6.2 million selling ...
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi ...